Non-selective Dopamine Antagonists
| Cat. No. | Product Name / Activity |
|---|---|
| 3737 | Asenapine maleate |
| Non-selective 5-HT, dopamine, adrenalin and histamine receptor antagonist; antipsychotic agent | |
| 0444 | Clozapine |
| Dopamine antagonist with some D4 selectivity; also 5-HT2A/2C antagonist | |
| 1847 | Eticlopride hydrochloride |
| D2 and D3 antagonist (D3 > D2) | |
| 4057 | Flupenthixol dihydrochloride |
| Dopamine antagonist | |
| 0931 | Haloperidol hydrochloride |
| Dopamine antagonist; displays some D2 selectivity | |
| 1746 | Nemonapride |
| Highly potent D2-like antagonist; also 5-HT1A agonist | |
| 0937 | Pimozide |
| D2-like antagonist; also high affinity 5-HT7 antagonist | |
| 1810 | Raclopride |
| Potent and selective D2 and D3 antagonist | |
| 0894 | (RS)-(±)-Sulpiride |
| Standard selective D2-like antagonist | |
| 0895 | (S)-(-)-Sulpiride |
| Standard selective D2-like antagonist | |
| 3070 | Thioridazine hydrochloride |
| Dopamine receptor antagonist; antipsychotic |
Dopamine Scientific Review
Our Dopamine receptors review gives an overview of the dopamine receptor subtypes, and the receptor agonists and antagonists used to study them.
Request copyRequest PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF